0001171843-21-004627.txt : 20210630 0001171843-21-004627.hdr.sgml : 20210630 20210630165010 ACCESSION NUMBER: 0001171843-21-004627 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210630 DATE AS OF CHANGE: 20210630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Robert CENTRAL INDEX KEY: 0001815574 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38298 FILM NUMBER: 211062534 MAIL ADDRESS: STREET 1: C/O ZOMEDICA CORP. STREET 2: 100 PHOENIX DRIVE, SUITE 125 CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 125 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 369-2555 MAIL ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 125 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: Zomedica Pharmaceuticals Corp. DATE OF NAME CHANGE: 20160908 4 1 ownership.xml X0306 4 2021-06-30 0 0001684144 Zomedica Corp. ZOM 0001815574 Cohen Robert C/O ZOMEDICA CORP. 100 PHOENIX DRIVE, SUITE 125 ANN ARBOR MI 48108 1 1 0 0 CEO Common Stock, without par value 2021-06-30 4 M 0 543750 0.23 A 543750 D Common Stock, without par value 2021-06-30 4 S 0 543750 0.8227 D 0 D Stock option (right to buy) 0.23 2021-06-30 4 M 0 543750 0 D 2030-12-30 Common Stock, without par value 543750 10262500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.815 to $0.845 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021. /s/ John Hogoboom, attorney-in-fact 2021-06-30